187 related articles for article (PubMed ID: 17980909)
1. Expression of the GPI-anchored receptor Prv-1 enhances thrombopoietin and IL-3-induced proliferation in hematopoietic cell lines.
Dillon M; Minear J; Johnson J; Lannutti BJ
Leuk Res; 2008 May; 32(5):811-9. PubMed ID: 17980909
[TBL] [Abstract][Full Text] [Related]
2. Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.
Teofili L; Giona F; Martini M; Cenci T; Guidi F; Torti L; Palumbo G; Amendola A; Foà R; Larocca LM
J Clin Oncol; 2007 Mar; 25(9):1048-53. PubMed ID: 17369568
[TBL] [Abstract][Full Text] [Related]
3. Detection of abnormalities of PRV-1, TPO, and c-MPL genes detected by fluorescence in situ hybridization in essential thrombocythemia.
Puigdecanet E; Espinet B; Villa O; Florensa L; Besses C; Serrano S; Solé F
Cancer Genet Cytogenet; 2006 May; 167(1):39-42. PubMed ID: 16682284
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine 462 of the membrane-proximal F'-G' loop of murine Mpl is not essential for high-affinity binding of thrombopoietin.
Sabath DF; Lin N; Sabath DE; Kaushansky K; Broudy VC
Cytokine; 2000 Feb; 12(2):127-33. PubMed ID: 10671297
[TBL] [Abstract][Full Text] [Related]
5. A functional erythropoietin receptor is necessary for the action of thrombopoietin on erythroid cells lacking c-mpl.
Rouleau C; Cui K; Feldman L
Exp Hematol; 2004 Feb; 32(2):140-8. PubMed ID: 15102474
[TBL] [Abstract][Full Text] [Related]
6. Xanthocillins as thrombopoietin mimetic small molecules.
Sakai R; Nakamura T; Nishino T; Yamamoto M; Miyamura A; Miyamoto H; Ishiwata N; Komatsu N; Kamiya H; Tsuruzoe N
Bioorg Med Chem; 2005 Dec; 13(23):6388-93. PubMed ID: 16115772
[TBL] [Abstract][Full Text] [Related]
7. A novel thrombopoietin signaling defect in polycythemia vera platelets.
Moliterno AR; Siebel KE; Sun AY; Hankins WD; Spivak JL
Stem Cells; 1998; 16 Suppl 2():185-92. PubMed ID: 11012190
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.
Nishino T; Miyaji K; Ishiwata N; Arai K; Yui M; Asai Y; Nakauchi H; Iwama A
Exp Hematol; 2009 Nov; 37(11):1364-1377.e4. PubMed ID: 19744539
[TBL] [Abstract][Full Text] [Related]
9. Expression of polycythemia rubra vera-1 decreases the dependency of cells on growth factors for proliferation.
Mnjoyan Z; Li J; Afshar-Kharghan V
Haematologica; 2005 Mar; 90(3):405-6. PubMed ID: 15749675
[TBL] [Abstract][Full Text] [Related]
10. Screening for MPL mutations in essential thrombocythemia and primary myelofibrosis: normal Mpl expression and absence of constitutive STAT3 and STAT5 activation in MPLW515L-positive platelets.
Glembotsky AC; Korin L; Lev PR; Chazarreta CD; Marta RF; Molinas FC; Heller PG
Eur J Haematol; 2010 May; 84(5):398-405. PubMed ID: 20113333
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic control of PRV-1 expression on neutrophils.
Jelinek J; Li J; Mnjoyan Z; Issa JP; Prchal JT; Afshar-Kharghan V
Exp Hematol; 2007 Nov; 35(11):1677-83. PubMed ID: 17976520
[TBL] [Abstract][Full Text] [Related]
12. Impact of chicken thrombopoietin and its receptor c-Mpl on hematopoietic cell development.
Bartunek P; Karafiat V; Bartunkova J; Pajer P; Dvorakova M; Kralova J; Zenke M; Dvorak M
Exp Hematol; 2008 Apr; 36(4):495-505. PubMed ID: 18243490
[TBL] [Abstract][Full Text] [Related]
13. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera.
Moliterno AR; Hankins WD; Spivak JL
N Engl J Med; 1998 Feb; 338(9):572-80. PubMed ID: 9475764
[TBL] [Abstract][Full Text] [Related]
14. Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells.
Romanelli RG; Petrai I; Robino G; Efsen E; Novo E; Bonacchi A; Pagliai G; Grossi A; Parola M; Navari N; Delogu W; Vizzutti F; Rombouts K; Gentilini P; Laffi G; Marra F
Am J Physiol Gastrointest Liver Physiol; 2006 Jan; 290(1):G120-8. PubMed ID: 16150872
[TBL] [Abstract][Full Text] [Related]
15. Regulation of polymorphonuclear cell activation by thrombopoietin.
Brizzi MF; Battaglia E; Rosso A; Strippoli P; Montrucchio G; Camussi G; Pegoraro L
J Clin Invest; 1997 Apr; 99(7):1576-84. PubMed ID: 9120001
[TBL] [Abstract][Full Text] [Related]
16. The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels.
Geddis AE; Fox NE; Kaushansky K
Exp Hematol; 2006 Jan; 34(1):82-6. PubMed ID: 16413394
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic markers in essential thrombocythemia.
Gale RE
Curr Hematol Rep; 2003 May; 2(3):242-7. PubMed ID: 12901346
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders.
Kralovics R; Skoda RC
Blood Rev; 2005 Jan; 19(1):1-13. PubMed ID: 15572213
[TBL] [Abstract][Full Text] [Related]
19. A preliminary investigation into the action of anagrelide: thrombopoietin-c-Mpl receptor interactions.
McCarty JM; Melone PD; Simanis JP; Kanamori D; Dessypris EN; Warshamana-Greene GS
Exp Hematol; 2006 Jan; 34(1):87-96. PubMed ID: 16413395
[TBL] [Abstract][Full Text] [Related]
20. Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist.
Erickson-Miller CL; DeLorme E; Tian SS; Hopson CB; Stark K; Giampa L; Valoret EI; Duffy KJ; Luengo JL; Rosen J; Miller SG; Dillon SB; Lamb P
Exp Hematol; 2005 Jan; 33(1):85-93. PubMed ID: 15661401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]